Tag: Nilesh Gupta
Lupin receives Health Canada approval for biosimilar Pegfilgrastim
This product will be marketed under the brand name Armlupeg® and manufactured at Lupin’s Biotech facility at Pune, India
Lupin gets EIR from US FDA for its Ankleshwar manufacturing facility
The inspection of the facility was conducted from August 16-19, 2022
Lupin appoints Diana Amador-Toro as Senior Vice President, Global Compliance
Diana is a senior leader with more than 38 years of field experience in U.S. FDA’s Office of Regulatory Affairs (ORA)
Pharma industry reiterates its commitment to US$ 130 billon by 2030
Innovation, R&D, partnership & policy support to be key growth drivers as echoed at Global Innovation Summit-2021 organized by Indian Pharmaceutical Alliance
Lupin acquires Southern Cross Pharma in Australia
As a part of the transaction, Generic Health will gain access to over 60 registered products having sales of over AUD 30 Mn (approximately USD 22 Mn)...................
Lupin gets US-FDA nod for its Pegfilgrastim biosimilar application
The Biologics License Application (BLA) submission is supported by similarity data from analytical, pharmacokinetic, pharmacodynamic and immunogenicity studies........................